Sheng Lu

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)

G. Chen, J. Feng, Caicun Zhou et al. · Annals of Oncology · 2013 · 119 citations · Full text

Medicine, Cancer Management, Phase Iii +6

Two-dimensional ZnO nanoflakes coated mesh for the separation of water and oil

Hong Li, Maojun Zheng, Li Ma et al. · Materials Research Bulletin · 2012 · 46 citations

Materials Science, Chemical Engineering, Engineering +11

A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy

Nan Wang, Wenqi Xi, Sheng Lu et al. · Frontiers in Oncology · 2021 · 24 citations · Full text

Machine-learning-assisted prediction of surgical outcomes in patients undergoing gastrectomy

Sheng Lu, Min Yan, Chen Li et al. · Chinese Journal of Cancer Research · 2019 · 23 citations · Full text

Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases

Min Shi, Zhongyin Yang, Sheng Lu et al. · BMC Cancer · 2021 · 21 citations · Full text